Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKB | Q96GD4 | 3/20 | 0.77 |
| ▸ | KDR | P35968 | 2/20 | 0.77 |
| ▸ | PARP1 | P09874 | 12/20 | 0.58 |
| ▸ | DHODH | Q02127 | 3/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 2/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6581347 | 0.92 | AURKB (0.65) | AURKBKDRPARP1DHODHGRIN2B | |
| SCHEMBL6581349 | 0.92 | AURKB (0.64) | AURKBKDRPARP1DHODHGRIN2B | |
| SCHEMBL6381152 | 0.88 | PARP1 (0.73) | AURKBKDRPARP1DHODHGRIN2B | |
| SCHEMBL6383679 | 0.87 | PARP1 (0.72) | AURKBKDRPARP1DHODHGRIN2B | |
| SCHEMBL3577924 | 0.87 | AURKB (1.00) | AURKBKDRPARP1DHODHAURKA | |
| SCHEMBL6580981 | 0.86 | KDR (0.56) | AURKBKDRPARP1DHODHHDAC6 | |
| SCHEMBL6381588 | 0.83 | PARP1 (0.74) | AURKBKDRPARP1DHODHGRIN2B | |
| SCHEMBL6582934 | 0.82 | AURKB (0.51) | AURKBKDRPARP1AURKA | |
| SCHEMBL6384291 | 0.82 | PARP1 (0.73) | AURKBKDRPARP1DHODHGRIN2B | |
| SCHEMBL6580774 | 0.81 | PARP1 (0.56) | AURKBKDRPARP1DHODHGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1391457-B1 | Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors | ABBVIE DEUTSCHLAND (DE) | 2013-12-25 | — | — | EP | disclosed |
| EP-1127052-B1 | SUBSTITUTED 2-PHENYLBENZIMIDAZOLES, THE PRODUCTION THEREOF AND THEIR USE | ABBOTT GMBH & CO KG (DE) | 2004-12-08 | — | — | EP | disclosed |
| EP-1391457-A1 | Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors | Abbott GmbH & Co. KG (DE) | 2004-02-25 | — | — | EP | disclosed |